Check Bioaffinity Technologies Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$5.4M
EPS (TTM)
-0.48
Dividend Yield
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Bioaffinity Technologies Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
NA | $5.4M | NA | NA | -152.18% | |
BUY | $51.3B | 80.65% | 53.18 | 24.41% | |
BUY | $35.9B | 27.51% | 29.54 | 17.97% | |
BUY | $31.7B | 18.82% | 27.1 | 7.88% | |
BUY | $178.5B | 10.16% | 27.32 | 15.24% |
The Bioaffinity Technologies Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Bioaffinity Technologies Inc investment value today
Current value as on today
₹14,294
Returns
Returns from Bioaffinity Technologies Inc Stock
Dollar Returns*
₹4,953 (+4.95%)
Search interest for Bioaffinity Technologies Inc Stock has increased by 98% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:98% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Idexx Laboratories, Inc. has given 25.3% return, outperforming this stock by 115.3%
Against Peers
In the last 3 years, Idexx Laboratories, Inc. has given 87.1% return, outperforming this stock by 182.9%
Price Dip
In the last 7 days, BIAF stock has moved down by -28.4%
Profit Down
Netprofit is down for the last 2 quarters, -2.66M → -4.06M (in $), with an average decrease of 52.7% per quarter
Revenue Fall
Revenue is down for the last 6 quarters, 2.40M → 1.26M (in $), with an average decrease of 11.2% per quarter
Organisation | Bioaffinity Technologies Inc |
Headquarters | 3300 Nacogdoches Road, San Antonio, TX, United States, 78217 |
CEO | Ms. Maria Zannes J.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. William Bauta Ph.D. | Chief Science Officer |
Ms. Julie Anne Overton | Director of Communications |
Ms. Maria Zannes J.D. | Founder, President, CEO & Director |
Mr. Xavier T. Reveles M.S. | Chief Operating Officer |
Mr. Timothy P. Zannes J.D. | Executive VP, Secretary & General Counsel |
Mr. Dallas J. Coleman | Vice President of sales |
Dr. Gordon Downie M.D., Ph.D. | Chief Medical Officer |
Mr. Steven Girgenti | Founder & Executive Chairman of the Board |
Mr. James Michael Edwards CPA, M.B.A. | Chief Financial Officer |
Bioaffinity Technologies Inc share price today is $0.17 as on . Bioaffinity Technologies Inc share today touched a day high of $0.19 and a low of $0.13.
Bioaffinity Technologies Inc share touched a 52 week high of $2.26 on and a 52 week low of $0.16 on . Bioaffinity Technologies Inc stock price today i.e. is trending at $0.17,which is 92.48% down from its 52 week high and 3.72% up from its 52 week low.
Bioaffinity Technologies Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Bioaffinity Technologies Inc (BIAF) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Bioaffinity Technologies Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Bioaffinity Technologies Inc share’s latest price of $0.17 as on September 18, 2025 at 11:37 pm IST, you will get 58.8235 shares of Bioaffinity Technologies Inc. Learn more about
fractional shares .